Biphenotypic blast crisis of chronic myelogenous leukemia: Abnormalities of p53 and retinoblastoma genes

Leukemia and Lymphoma

Volumn 25, Issue 5-6, 1997, Pages 573-578

  Ishikura, Hideki ^a,d   Yufu, Yuji ^a   Yamashita, Sayuri ^a   Abe, Yasunobu ^b   Okamura, Takashi ^a   Motomura, Seiji ^c   Nishimura, Junji ^a   Nawata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Shakaihoken Nakabaru Hospital   (Japan)

^c Fukuoka Teishin Hospital   (Japan)

^d NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN P53;

ADULT; ARTICLE; BLAST CELL; BLAST CELL CRISIS; CANCER GROWTH; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOLECULAR GENETICS; MYELOID LEUKEMIA; PHENOTYPE; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

EID: 0030806783     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709039046     Document Type: Article

References (32)

1. bcr/abl gene of the Philadelphia chromosome. Science, 247, 824-829.
2. Cannistra, S. A. (1990) Chronic myelogenous leukemia as a model for the genetic basis of cancer, Hematol. Oncol Clin. North. Am., 4, 337-357.
3. Kantarjian, H. M., Deisseroth, A., Kurzrock, R., Estrov, Z. and Talpaz M. (1993). Chronic myelogenous leukemia: A concise update. Blood, 82, 691-703.
4. Thomas, E. D., Clift, R. A., Fefer, A., Appelbaum, F. R., Beatty, P., Bensinger, W. I., Buckner, C. D., Cheever, M. A., Deeg, H J., Doney, K., Flournoy, N., Greenberg, P., Hansen, J. A., Martin, P., McGuffin, R., Ramberg, R., Sanders, J. E., Singer, J., Stewart, P., Storb, R., Sullivan, K., Weiden, P. L. and Witherspoon, R. (1986). Marrow transplantation for the treatment of chronic myelogenous leukemia, Ann. Inter. Med., 104, 155-163.
5. Liu, E., Hjelle, B. and Bishop, J. M. (1988) Transforming genes in chronic myelogenous leukemia, Pro. Natl. Acad. Sci. USA, 85, 1952-1956.
6. McCarthy, D. M., Rassool, F. V., Goldman, J. M., Graham, S. V. and Birnie, G. D. (1984). Genomic alterations involving the c-myc proto-oncogene locus during the evolution of a case of chronic granulocytic leukemia, Lancet, ii, 1362-1365.
7. Ahuja, H. G., Jat, P. S., Foti, A., Bar-Eli, M. and Cline, M. S. (1991). Abnormalities of the retinoblastoma gene in pathogenesis of acute leukemia, Blood, 78, 3259-3268.
8. Ahuja, H., Bar-Eli, M., Advani, S. H., Benchimol, S. and Cline, M. J. (1989). Alterations of p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia, Proc. Natl. Acad Sci. USA, 86, 6783-6787.
9. Mulligan, M. L., Matlashewski, G. J., Scrable, H. J. and Cavanee, W. K. (1990). Mechanisms of p53 loss in human sarcomas, Proc. Natl. Acad. Sci. USA, 87, 5863-5867.
10. Yandell, D. W., Se, D. and Campbell, T. A. (1989). Oncogenic point mutation in the human retinoblastoma gene: their application to genetic counseling, N. Engl J. Med., 321, 1689-1695.
11. Kelman, Z., Prokocimer, M., Peller, S., Kahn, Y., Rechavi, G., Manor, Y., Cohen, A. and Rotter, V. (1989). Rearrangements of p53 gene in Philadelphia positive chronic myelocytic leukemia. Blood, 74, 2318-2324.
12. Marshal, R., Shtalrid, M., Talpaz, M., Kantarjian, H., Smith, L., Beran, M., Cork, A., Turjillo, J., Gutterman, J. and Deisseroth, A. (1990). Rearrangement and expression of p53 gene in the chronic phase and blast crisis of chronic myelogenous leukemia. Blood, 75, 180-189.
13. Cline, M. J., Jat, P. S. and Foti, A. (1992). Molecular mechanisms in the evolution of chronic myelocytic leukemia, Leuk. Lymph., 7, 283-287
14. Maniatis, T., Fritsch, E. F. and Sambrook J. J. (1982). In: Molecular cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
15. Wiggs, J., Nordenskjold, M., Yandell, D., Rapaport, J., Grondin, V., Janson, M., Werelius, B., Petersen, R., Craft, A., Riedel, K., Liberfarb, R., Walton, D., Wilson, W. and Dryja, T. P. (1988) Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene, N. Engl. J Med. 318, 151-157
16. Ahuja, H., Bar-Eli, M., Clarke, P., Snyder, D., Foreman, S., Goldman, J. and Cline, M. J. (1989). p53 gene alterations in blast crisis of chronic myelogenous leukemia. Cancer Cells, 7, 117-120.
17. Gale, R. P. and Ben-Bassat, I. (1987). Annotation: Hybrid acute leukaemia, Bri. J. Haematol., 65, 261-264.
18. Alimena, G., Dallapiccola, B., Gaslaloi, R., Mandelli, F., Brandt, L., Mitelman, F. and Nilsson, P. G (1982). Chromosomal, morphological and clinical correlations in blastic crisis of chronic myeloid leukaemia. A study of 69 cases, Scand. J. Haematol., 28, 103-117.
19. Griffin, J. D., Todd III, R. F., Ritz, J., Nadler, L. M., Canellos, G. P., Rosenthal, D., Gallivan, M., Beveridge, R. P., Weinstein, H., Karp, D. and Schlossman, S. F. (1983). Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood, 61, 85-91.
20. Okawa, H. (1988). Immunologic classification of leukemia, Pediatric review, 21, 41-65.
21. Rowley, J. D. and Testa, J. R. (1982). Chromosome abnormalities in malignnt hematologic diseases, Adv. Cancer Res., 36, 103-148.
22. Miller, C., Mohandas, T., Wolf, D., Prokocimer, M., Rotter, V. and Koeffler, H. P. (1986). Human p53 gene localized to short arm of chromosome 17, Nature, 319, 783-784.
23. Feinstein, E., Cimino, G., Gale, R. P., Alimena, G., Berthier, R., Kishi, K., Goldman, JL, Zaccaria, A., Berrabi, A. and Canaani, E. (1991). p53 in chronic myelogenous leukemia in acute phase, Pro. Natl. Acad. Sci. USA, 85, 1952-1956.
24. Nakai, H., Misawa, S., Taniwaki, M., Horiike, S., Takashima, T., Seriu, T., Nakagawa, H., Fujii, H., Shimazaki, C., Maruo, N., Akaogi, T., Uike, N., Abe, T. and Kashima, K. (1994). Prognostic significance of loss of a chromosome 17p and p53 gene mutation in blast crisis of chronic myeloaenous leukemia, Br. J. Haematol., 87, 425-127.
25. Weinberg, R. A. (1991). Tumor suppressor genes, Science, 254, 1138-1146.
26. Furukawa, Y., DeCapno, J. A., Belvin, M. and Griffin, J. D. (1991). Heterogenous expression of the product of the retinoblastoma susceptibility gene in primary human leukemia cells. Oncogene, 6, 1343-1346.
27. Furukawa, Y. (1993). Tumor suppressor genes and their role in abnormal production of leukocytes (Leukemogenesis), Jpn. J. Clin. Hematol., 34, 572-577
28. Tang, J-L., Yeh, S-H., Chen, P-J., Lin, M-T., Tien, H-F. and Chen, Y-C. (1992). Inactivation of the retinoblastoma gene in acute myelogenous leukaemia, Br. J. Haematol., 82, 502-507.
29. Komblau, S. M., Xu, H-J., Zhang, W., Hu, S-W., Beran, M., Smith, T. L., Hester, J., Estey, E., Benedict, W. F. and Deisserroth A. B. (1994) Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia, Blood, 84, 256-261.
30. Cline, M. J. (1994). Mechanisms of disease: The molecular basis of leukemia, N. Eng. J. Med, 330, 328-336.
31. Towatari, M., Adachi, K., Kato, H. and Saito, H. (1991). Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia, Blood, 78, 2178-2181.
32. Sill, H., Goldman, J. M. and Cross, N. C. P. (1995). Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood, 85, 2013-2016.